Pharmacologic therapy for osteoarthritis--the era of disease modification.
about
Diacerein for osteoarthritisBisphosphonates for osteoarthritisAssociation between serum levels of 25-hydroxyvitamin D and osteoarthritis: a systematic reviewHip Osteoarthritis: Etiopathogenesis and Implications for ManagementThe Monoiodoacetate Model of Osteoarthritis Pain in the MouseFirst-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort.Imaging and T2 relaxometry of short-T2 connective tissues in the knee using ultrashort echo-time double-echo steady-state (UTEDESS).Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasisA benzamide-linked small molecule HS-Cf inhibits TNF-α-induced interferon regulatory factor-1 in porcine chondrocytes: a potential disease-modifying drug for osteoarthritis therapeutics.Cyclic phosphatidic acid relieves osteoarthritis symptoms.The identification of CD163 expressing phagocytic chondrocytes in joint cartilage and its novel scavenger role in cartilage degradation.Hydrogen sulphide decreases IL-1β-induced activation of fibroblast-like synoviocytes from patients with osteoarthritis.Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis.Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening.Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) shows no change in cartilage structural composition after viscosupplementation in patients with early-stage knee osteoarthritis.Quantitative radiologic imaging techniques for articular cartilage composition: toward early diagnosis and development of disease-modifying therapeutics for osteoarthritis.Intra-articular transplantation of atsttrin-transduced mesenchymal stem cells ameliorate osteoarthritis development.Engineering lubrication in articular cartilageVariant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis.Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches.Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial.Repair of cartilage defects in osteoarthritis rats with induced pluripotent stem cell derived chondrocytes.Tenascin-C fragments are endogenous inducers of cartilage matrix degradation.Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment.Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study.Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?Emerging drugs for osteoarthritis.A comparison of three-dimensional culture systems to evaluate in vitro chondrogenesis of equine bone marrow-derived mesenchymal stem cells.Glucosamine activates autophagy in vitro and in vivo.TSG-6 activity as a novel biomarker of progression in knee osteoarthritis.Are we moving in the right direction with osteoarthritis drug discovery?Metric properties of advanced imaging methods in osteoarthritis of the hand: a systematic review.Functional articular cartilage repair: here, near, or is the best approach not yet clear?Biologic agents in osteoarthritis: hopes and disappointments.Involvement of the endocannabinoid system in osteoarthritis pain.Future nanomedicine for the diagnosis and treatment of osteoarthritisThe role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive.Emerging drugs for the treatment of knee osteoarthritis.Cross-species gene modules emerge from a systems biology approach to osteoarthritis.Clinical Validation of Pain Management Manipulative Therapy for Knee Osteoarthritis With the Squeeze-Hold Technique: A Case Series.
P2860
Q24200470-FD98F546-393A-486A-8132-96F7F55CB3F0Q24202794-F7778C82-4EF4-4B44-90E3-CEBE8743D69BQ26853252-073E3FDD-3891-41C4-8A2A-1269C2A169FEQ28068167-7067D279-5F2B-4DE6-B893-D60E3376FCFBQ28830426-44B28234-6896-4EEA-8140-153BAC640FE7Q30714596-26320881-45D3-49DD-96B3-64BB2DA11D34Q31154134-62F1C54A-D5DA-4200-84FA-4DDA284F21ECQ33760068-7AA009B5-6AC6-4EE5-858C-F2E4784BD4DCQ34000230-EBD37AA3-6E12-42D6-AA65-DD7B06E9C749Q34078519-C9EE9C32-EFA9-4E8E-8458-8FCB7751AF43Q34551313-A2B3B636-0669-4DCF-B427-EDB43D4BC7A8Q34885481-8ECCF2C8-95FE-499B-A27D-FC29988DC3FEQ35007761-280206F8-06C1-42D5-87CA-0A2C2485AAA9Q35020639-521C2A74-C2C0-445D-AC78-993423123DC5Q35040328-3B86686E-3305-4E7B-AFAD-F11C663F3F65Q35064564-6B5AE47F-AA5D-4184-BBA8-C444DDDD9F27Q35552093-2203B6E5-A559-4019-AB8A-466E42A62589Q35849841-E5E6570F-55DA-4CCF-9218-268EF83CA6E1Q35922988-AA2298FF-7784-4C5B-AA53-1C1732434C77Q36057665-4F17AA84-A810-4163-8A99-3A9961016C85Q36071944-7B8C79EE-6B95-47EC-AC17-7D83455116DFQ36187930-B35DF389-A7C8-4342-AEA6-584C898D4CA6Q36195430-E6C0D6B2-C32F-4993-856F-F0D64C9ACD15Q36428199-F591EAD6-FA81-44C8-8E3D-39EED4FE84E5Q36517447-16664765-B271-47AE-AC38-407B15E6110FQ36894945-B07B2B9C-CA2F-481B-8A43-4391D066DFE4Q36931658-3D204F23-97E8-40E6-874D-F178D03656CFQ37143044-F3B6EBB6-7E68-49C7-BBBD-7B8691130A64Q37168084-6B5DB0BD-D140-46DF-BA14-DF33EC50F57FQ37612457-B4143403-C780-47A6-A94D-E5D70198CE35Q37956680-6DE52171-275C-4A2D-AE27-104971BA0737Q38076679-4F7F0F10-3EC9-4E94-A20B-CAB5E6F974B7Q38090916-541371B9-5E4F-4DF2-A0E2-CF047EB7D843Q38094906-97F7B31F-6FCE-47F2-997E-2976E1340743Q38185076-7A45812E-B1F3-4C36-8C7F-90C0C49CF5CCQ38269127-79D96F50-AFB5-4E8C-9A99-1BA9328F5C7CQ38320224-B406D117-C986-499E-B0DA-08F3D3BFB0BBQ38417521-3BDA3EF5-762E-4D5C-8DF0-40D899689DA3Q38709510-5F803775-B90E-45B3-8A81-48E0B9E55F18Q38755398-6C8A2DF0-09D9-4AC6-9130-DE4FE253ECAE
P2860
Pharmacologic therapy for osteoarthritis--the era of disease modification.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Pharmacologic therapy for osteoarthritis--the era of disease modification.
@en
Pharmacologic therapy for osteoarthritis--the era of disease modification.
@nl
type
label
Pharmacologic therapy for osteoarthritis--the era of disease modification.
@en
Pharmacologic therapy for osteoarthritis--the era of disease modification.
@nl
prefLabel
Pharmacologic therapy for osteoarthritis--the era of disease modification.
@en
Pharmacologic therapy for osteoarthritis--the era of disease modification.
@nl
P2860
P356
P1476
Pharmacologic therapy for osteoarthritis--the era of disease modification.
@en
P2093
David J Hunter
P2860
P2888
P356
10.1038/NRRHEUM.2010.178
P407
P577
2010-11-16T00:00:00Z